Literature DB >> 7752094

Tolerance to the antinociceptive properties of morphine in the rat spinal cord: alteration of calcitonin gene-related peptide-like immunostaining and receptor binding sites.

D P Ménard1, D van Rossum, S Kar, F B Jolicoeur, K Jhamandas, R Quirion.   

Abstract

Tolerance to the spinal antinociceptive effects of morphine develops rapidly after its chronic administration. The mechanism involved in this phenomenon is unclear, but it is unlikely due to a direct regulation of spinal opioid peptides and their receptor binding sites. A variety of neuropeptides, especially the neurokinins and calcitonin gene-related peptide (CGRP) are concentrated in primary sensory afferents and have thus been proposed to play significant roles in spinal nociceptive mechanisms. However, their functions in the development of tolerance to the antinociceptive properties of morphine have not been explored fully. We therefore investigated the possible involvement of various sensory neuropeptides including CGRP, substance P, galanin, neurotensin and neuropeptide Y and their receptors in the dorsal horn of the spinal cord during the development of tolerance to the antinociceptive action of intrathecal morphine. Morphine sulfate (7.5 micrograms/microliters/hr) was administered continuously at lumbar level L4 using mini-osmotic pumps for 3, 5, 7 and 14 days. Tolerance to the antinociceptive effect of morphine was verified with the tail-immersion test and became evident on the 5th day of treatment. In tolerant animals, there was a marked increase in CGRP-like immunostaining and a decrease (30-45%) in [125I]human CGRP alpha binding in laminae I, II and III of the dorsal horn of the spinal cord. These changes coincided with the onset of morphine tolerance and persisted for the 14-day period during which tolerance was present. Similar changes were not observed in the immunostaining or binding of the other neuropeptides studied.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7752094

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  12 in total

1.  Blockade and reversal of spinal morphine tolerance by peptide and non-peptide calcitonin gene-related peptide receptor antagonists.

Authors:  K J Powell; W Ma; M Sutak; H Doods; R Quirion; K Jhamandas
Journal:  Br J Pharmacol       Date:  2000-11       Impact factor: 8.739

Review 2.  Paradoxical signal transduction in neurobiological systems.

Authors:  F C Colpaert; Y Frégnac
Journal:  Mol Neurobiol       Date:  2001 Aug-Dec       Impact factor: 5.590

3.  Spinal mediators that may contribute selectively to antinociceptive tolerance but not other effects of morphine as revealed by deletion of GluR5.

Authors:  A M Gregus; C N Inra; T P Giordano; A C S Costa; A M Rajadhyaksha; C E Inturrisi
Journal:  Neuroscience       Date:  2010-03-29       Impact factor: 3.590

4.  Characterization and effects on cAMP accumulation of adrenomedullin and calcitonin gene-related peptide (CGRP) receptors in dissociated rat spinal cord cell culture.

Authors:  Mohammad A Takhshid; David R Poyner; Jean-Guy Chabot; Alain Fournier; Weiya Ma; Wen-Hua Zheng; Ali A Owji; Remi Quirion
Journal:  Br J Pharmacol       Date:  2006-05-15       Impact factor: 8.739

5.  The role of spinal neuropeptides and prostaglandins in opioid physical dependence.

Authors:  Tuan Trang; Maaja Sutak; Remi Quirion; Khem Jhamandas
Journal:  Br J Pharmacol       Date:  2002-05       Impact factor: 8.739

6.  Spinal administration of lipoxygenase inhibitors suppresses behavioural and neurochemical manifestations of naloxone-precipitated opioid withdrawal.

Authors:  Tuan Trang; Maaja Sutak; Remi Quirion; Khem Jhamandas
Journal:  Br J Pharmacol       Date:  2003-08-26       Impact factor: 8.739

7.  Sustained morphine-induced sensitization and loss of diffuse noxious inhibitory controls in dura-sensitive medullary dorsal horn neurons.

Authors:  Akiko Okada-Ogawa; Frank Porreca; Ian D Meng
Journal:  J Neurosci       Date:  2009-12-16       Impact factor: 6.167

8.  Ultra-low dose naltrexone attenuates chronic morphine-induced gliosis in rats.

Authors:  Theresa-Alexandra M Mattioli; Brian Milne; Catherine M Cahill
Journal:  Mol Pain       Date:  2010-04-16       Impact factor: 3.395

9.  Opiate-induced persistent pronociceptive trigeminal neural adaptations: potential relevance to opiate-induced medication overuse headache.

Authors:  M De Felice; F Porreca
Journal:  Cephalalgia       Date:  2009-05-11       Impact factor: 6.292

Review 10.  Molecular and cellular mechanisms of the age-dependency of opioid analgesia and tolerance.

Authors:  Jing Zhao; Xin Xin; Guo-xi Xie; Pamela Pierce Palmer; Yu-guang Huang
Journal:  Mol Pain       Date:  2012-05-21       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.